A multinational biopharmaceutical company, which is present in more than 100 countries, faced significant inefficiencies across operations, compliance, customer outreach, engagement, and marketing technology integration, all of which negatively impacted the engagement of healthcare professionals (HCPs). Moreover, strict adherence to regulatory guidelines regarding consent management was paramount, and their existing infrastructure lacked the necessary solutions to effectively tackle these challenges.